Filing Details
- Accession Number:
- 0001209191-21-063263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-05 18:24:17
- Reporting Period:
- 2021-11-04
- Accepted Time:
- 2021-11-05 18:24:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1370053 | Anaptysbio Inc | ANAB | Pharmaceutical Preparations (2834) | 203828755 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654495 | Hamza Suria | C/O Anaptysbio, Inc. 10770 Wateridge Circle, Suite 210 San Diego CA 92121 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-04 | 6,059 | $1.12 | 73,695 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-04 | 6,059 | $35.00 | 67,636 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 14,302 | $1.12 | 81,938 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-05 | 14,302 | $35.00 | 67,636 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-11-04 | 6,059 | $0.00 | 6,059 | $1.12 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-11-05 | 14,302 | $0.00 | 14,302 | $1.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,302 | 2021-12-08 | No | 4 | M | Direct | |
| 0 | 2021-12-08 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021.
- In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.
Billionaire Hedge Funds
